Dexcom Stelo: A Breakthrough in Over-the-Counter Continuous Glucose Monitoring

Monday, 26 August 2024, 04:36

Continuous glucose sensors are now more accessible as Dexcom launches its OTC product, Stelo, in the US. This innovative glucose monitor, priced at up to $99, offers unprecedented convenience for diabetes management. Clearances from regulatory bodies mark a new era for personal health technology.
LivaRava_Technology_Default_1.png
Dexcom Stelo: A Breakthrough in Over-the-Counter Continuous Glucose Monitoring

Introducing Dexcom Stelo

Dexcom has launched its over-the-counter continuous glucose monitor, Stelo, in the United States, making available a tool designed to help individuals manage their glucose levels effectively.

Key Features of Stelo

  • OTC availability enhances accessibility.
  • Affordably priced at up to $99.
  • Regulatory clearances ensure safety and efficacy.

Impact on Diabetes Management

This launch marks a significant milestone in personal health technology, offering new solutions for those managing diabetes.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most reliable and up-to-date tech news. Stay informed and elevate your tech expertise effortlessly.

Subscribe